Bezafibrate inhibits HMG-CoA reductase activity in incubated blood mononuclear cells from normal subjects and patients with heterozygous familial hypercholesterolaemia-Reference-Cited by-同舟云学术

Bezafibrate inhibits HMG-CoA reductase activity in incubated blood mononuclear cells from normal subjects and patients with heterozygous familial hypercholesterolaemia

Published:1989-05 Issue:3 Volume:21 Page:247-254
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Blasi Francesco,Sommariva Domenico,Cosentini Roberto,Cavaiani Bruna,Fasoli Angelo

Publisher

Elsevier BV

Subject

Pharmacology

Reference26 articles.

1. Lipoproteins and coronary heart disease;Arntz,1980

2. Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia

3. Changes in serum lipoprotein pattern following bezafibrate. Differential effects in type IIa and in type IIb hyperlipoproteinemic patients

4. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver

5. Feedback Control of Mevalonate Synthesis by Dietary Cholesterol

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omega-3 fatty acids for a better mental state in working populations - Happy Nurse Project: A 52-week randomized controlled trial;Journal of Psychiatric Research;2018-07

2. Effect of Bezafibrate Treatment on the Altered Lipoprotein Profiles in Hypertriglyceridemic Subjects;Journal of Atherosclerosis and Thrombosis;2000

3. Bezafibrate;Drugs;1996-11

4. Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interaction;Atherosclerosis;1995-04

5. Effect of a long-term treatment with lovastatin or fenofibrate on hepatic and cardiac ubiquinone levels in cardiomyopathic hamster;Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism;1993-07